New Data Show Superiority of Abbott's TriClip™ Device Compared to Medical Therapy for Tricuspid Regurgitation
Go back to New Data Show Superiority of Abbott's TriClip™ Device Compared to Medical Therapy for Tricuspid Regurgitation| Abbott Laboratories (NYSE: ABT) | Delayed: 102.98 +0.37 (0.36%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $102.61 | 52 Week High | $46.38 | |||
| Open | $102.27 | 52 Week Low | $36.00 | |||
| Day High | $103.20 | P/E | 68.65 | |||
| Day Low | $101.84 | EPS | $1.50 | |||
| Volume | 5,018,235 | |||||
